Reliance Pharma-G    Plan:
Add to My Watchlist
Fund not rated
Value Research




 
 Current Stats & Profile
Latest NAV   72.3007 (20/05/13)
52-Week High   73.6734 (16/05/13)
52-Week Low   55.4343 (01/06/12)
Fund Category   Equity: Pharma
Type   Open End
Launch Date   May  2004
Risk Grade   Not Rated
Return Grade   Not Rated
Net Assets (Cr) *   655.13 (31/03/13) 
Benchmark   S&P BSE Healthcare
* Quarterly Average
 
 Trailing Returns
As on 20 May 2013 Fund Category
Year to Date 3.98 6.63
1-Month 5.89 5.68
3-Month 9.50 10.11
1-Year 28.12 29.44
3-Year 13.77 15.52
5-Year 24.45 18.56
Return Since Launch 24.70 --
Returns upto 1 year are absolute and over 1 year are annualised.
 Relative Performance (Fund Vs Category Average)

 Portfolio Summary
 Top Holdings    As on 30 Apr
 Name of Holding   % Net Assets
Divi's Laboratories    10.99
Ranbaxy Laboratories    9.24
Sanofi India    9.17
Cipla    9.02
Dr. Reddy's Lab    8.44

View additional holdings information
 
Top 5 Sectors % Net Asset
As on 30/04/2013
Healthcare   94.32
FMCG   3.64
   Indicates an increase or decrease or no change in holding since last portfolio
 Indicates a new holding since last portfolio.
 News and Analysis
Headline Date Story Type
Reliance MF Declares dividend under three Equity Schemes   07 Jan 2013   Fund News
Lost its Act   28 Dec 2012   Fund Family Update
Powering Up   12 Dec 2012   Interview
Boosting the Power Sector   11 Dec 2012   Interview
Reliance MF Declares Dividend in 5 Equity Funds   13 Mar 2012   Fund News
Dividend Declaration under Reliance Mutual Fund   21 Feb 2011   Fund News
Reliance Pharma: Dividend Declaration   25 Aug 2009   Fund News
In The Pink Of Health   20 May 2008   Fundwire
Declaration of Dividends by Reliance Mutual Fund   14 Mar 2008   Fund News
Pink Health   28 Dec 2007   Fundwire

View all news/stories related to this fund
Value Research Star Rating